News
RSSS
2.790
-1.06%
-0.030
Financial Report: Quarterly Review of Research Solutions, Inc.
Press release · 6d ago
Weekly Report: what happened at RSSS last week (0506-0510)?
Weekly Report · 6d ago
Buy Rating Affirmed for Research Solutions on Robust Growth and Strategic Acquisitions
Analyst Allen Klee of Maxim Group reiterated a Buy rating on Research Solutions (RSSS – Research Report), with a price target of $ . The company’s third-quarter fiscal year 24 results exceeded expectations with a year-over-year revenue increase of 17%.
TipRanks · 05/11 11:25
Research Solutions Price Target Raised to $6.00/Share From $5.00 by Maxim Group
Dow Jones · 05/10 15:17
Research Solutions Is Maintained at Buy by Maxim Group
Dow Jones · 05/10 15:17
Research Solutions Inc reports results for the quarter ended in March - Earnings Summary
Research Solutions Inc reports results for the quarter ended in March. Revenue rose 17.2% to $12.12 million from a year ago. The company reported quarterly income of $76.3 thousand. Research Solutions Inc shares had fallen by 10.4% this quarter and gained 8.8% this year.
Reuters · 05/10 15:16
Maxim Group Maintains Buy on Research Solutions, Raises Price Target to $6
Benzinga · 05/10 15:06
Lake Street Keeps Their Buy Rating on Research Solutions (RSSS)
TipRanks · 05/10 12:55
RSSS Stock Earnings: Research Solutions Beats Revenue for Q3 2024
Research Solutions reported revenue of $12.12 million for the third quarter of 2024. The company did not report any EPS for the quarter. This was 1.47% better than the analyst estimate of $11.94 million for revenue. Research Solutions has not yet reported results for the fourth quarter of 2016.
Investorplace · 05/10 02:55
Research Solutions Inc. (RSSS) Reports Break-Even Earnings for Q3
NASDAQ · 05/09 22:15
Research Solutions Q3 Sales $12.115M Beat $11.938M Estimate
Benzinga · 05/09 22:11
Research Solutions GAAP EPS of $0.00 beats by $0.01, revenue of $12.1M beats by $0.16M
Research Solutions, Inc. (RSSS) reports Q3 GAAP EPS of $0.00 and revenue of $12.1M. Shares +0.35% AH. Earnings of Research Solutions in the quarter were better than expected. Research Solutions has a market capitalization of $1.1 billion.
Seeking Alpha · 05/09 21:24
Press Release: Research Solutions Reports Fiscal Third Quarter 2024 Results
Research Solutions, Inc. Reports 17% Revenue Increase, ARR of $16.6 Million Positive Net Income and Record Adjusted EBITDA for its fiscal third quarter ended March 31, 2024. Total revenue was $12.1 million, a 17% increase. Platform revenue up 76% to $4.0 million. Annual recurring revenue was up 82% year-over-year.
Dow Jones · 05/09 20:06
Press Release: Research Solutions Reports Fiscal -2-
NM's quarterly and nine months results for the period ended March 31, 2018. The company reported a decrease in EBITDA of 71.8%. The company's revenue for the quarter was $1.2 billion. The company expects to generate $2.5 billion in annual revenue.
Dow Jones · 05/09 20:06
*Research Solutions 3Q EPS 0c >RSSS
Dow Jones · 05/09 20:05
Weekly Report: what happened at RSSS last week (0429-0503)?
Weekly Report · 05/06 11:15
Weekly Report: what happened at RSSS last week (0422-0426)?
Weekly Report · 04/29 11:22
Long Cast Advisers Q1 2024 Letter
For the 1Q24 quarter (ended March 31, 2024), cumulative net returns improved 9%. Long Cast Advisers is concentrated on long-term investing, focused on small-cap companies. MTRX, PESI and QRHC were the biggest contributors to returns in the quarter.
Seeking Alpha · 04/27 10:35
Research Solutions Price Target Announced at $5.00/Share by Lake Street
Dow Jones · 04/23 15:47
Research Solutions Initiated at Buy by Lake Street
Dow Jones · 04/23 15:47
More
Webull provides a variety of real-time RSSS stock news. You can receive the latest news about Research Solutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About RSSS
Research Solutions, Inc. is a holding company. The Company provides two service offerings to its customers: a cloud-based software-as-a-service (SaaS) research platform (Platforms) typically sold through annual auto-renewing license agreements and the sale of published scientific, technical, and medical (STM) content sold as individual articles (Transactions) through the Platform. Its cloud-based SaaS research platform consists of proprietary software and Internet-based interfaces sold to customers for an annual subscription fee. Its platform allows customers to initiate orders, route orders for the lowest cost acquisition, manage transactions, obtain spending and usage reporting, automate authentication, and connect to in-house and third-party software systems. Customers can access the Platform through online Web interfaces and through Web service APIs that enable customers to leverage Platform features and functionality from within in-house and third-party software systems.